Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Relationship between the dynamic profile of LAT1 probe and tumoral blood flow: comparison study using 18F-FBPA, 18F-FAMT, and 15O-water PET

Masanao Aoki, Tadashi Watabe, Shushi Nagamori, Hayato Ikeda, Genki Horitsugi, Sadahiro Naka, Yasukazu Kanai, Hiroki Kato, Eku Shimosegawa, Yoshikatsu Kanai and Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1346;
Masanao Aoki
7Osaka-University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
6Nuclear Medicine and Tracer Kinetics Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shushi Nagamori
5Bio-System Pharmacology Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hayato Ikeda
2Department of Nuclear Medicine and Tracer Kinetics Osaka University Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Genki Horitsugi
1Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadahiro Naka
4Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasukazu Kanai
4Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Kato
1Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eku Shimosegawa
4Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshikatsu Kanai
5Bio-System Pharmacology Osaka University Graduate School of Medicine Suita Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
3Osaka University Graduate School of Medicine Suita, Osaka Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1346

Objectives 3-[18F]fluoro-α-methyl-L-tyrosine (FAMT) and 4-borono-2-[18F]fluoro-L-phenylalanine (FBPA) were both reported as tumor selective tracer, which accumulate through L-type amino acid transporter 1 (LAT1). We performed the dynamic PET of FAMT, FBPA, and 15O-water to estimate the effect of tumor blood flow on the accumulation of these tracers.

Methods Rats (F344 rats, male, 8 weeks old, 213.1±27.0 g) were prepared as xenograft model of C6 glioma (n=12, 14 days after the implantation) and MIAPaCa (human pancreatic cancer cell line) (n=4, 28 days after the implantation). Dynamic PET scans were performed just after injection of FAMT (33.4±7.7 MBq) or FBPA (27.3±5.1 MBq) up to 70min, 15O-water (63.1±13.3 MBq) up to 10min under isoflurane anesthesia by small animal PET. Regions of interest (ROIs) were placed on the tumor of each PET image and the time activity curves (TACs) were compared between glioma and MIAPaCa. We calculated K1 and k2 from the 15O-water PET using one tissue compartment model analysis by PMOD 3.4, in which ROIs of left ventricle cavity were placed as image derived input function. K1 (an index of tumoral blood flow) and k2 were compared by t-test.

Results TAC of FAMT showed a rapid increase and continuous wash-out pattern in glioma, while low uptake and slow wash-out pattern in MIAPaCa. Tumoral uptake showed marked difference in the early phase (SUV at 10min = 3.20±0.42 in glioma and 1.11±0.15 in MIAPaCa), whereas no significant difference was observed in the late phase (SUV at 70min = 1.16±0.16 in glioma and 1.09±0.07 in MIAPaCa). Similar uptake patterns were observed in TAC of FBPA for both glioma and MIAPaCa (SUV at 10min = 3.17±0.39 in glioma and 1.11±0.16 in MIAPaCa) although kinetic of FBPA was slow compared to FAMT. K1 of glioma (0.93±0.45 ml/ccm/min) was significantly higher than that of MIAPaCa (0.31±0.07) (p<0.01), and k2 of glioma (1.51±0.75 /min) was also significantly higher than that of MIAPaCa (0.42±0.13) (p<0.01). It was suggested that difference in tumoral blood flow and wash-out of the tumor affected the kinetic patterns of glioma and MIAPaCa.

Conclusions The SUV ratio of glioma to MIAPaCa during first 10min was close to the K1 ratio of glioma to MIAPaCa, suggesting the accumulations of FAMT and FBPA into the malignant tumors were mainly influenced by the tumoral blood flow in the early phase. $$graphic_011D658E-B56B-4AA0-B31B-9348FE626064$$ $$graphic_3BB62279-A3CA-41E5-BA8C-ED1D2B4FBA44$$ $$graphic_93152865-8E84-41A7-9A7C-F2C48FF6EAA6$$

View this table:
  • View inline
  • View popup

Tumoral blood flow volume

View this table:
  • View inline
  • View popup

SUV at 10 min in malignant tumors

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Relationship between the dynamic profile of LAT1 probe and tumoral blood flow: comparison study using 18F-FBPA, 18F-FAMT, and 15O-water PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Relationship between the dynamic profile of LAT1 probe and tumoral blood flow: comparison study using 18F-FBPA, 18F-FAMT, and 15O-water PET
Masanao Aoki, Tadashi Watabe, Shushi Nagamori, Hayato Ikeda, Genki Horitsugi, Sadahiro Naka, Yasukazu Kanai, Hiroki Kato, Eku Shimosegawa, Yoshikatsu Kanai, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1346;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Relationship between the dynamic profile of LAT1 probe and tumoral blood flow: comparison study using 18F-FBPA, 18F-FAMT, and 15O-water PET
Masanao Aoki, Tadashi Watabe, Shushi Nagamori, Hayato Ikeda, Genki Horitsugi, Sadahiro Naka, Yasukazu Kanai, Hiroki Kato, Eku Shimosegawa, Yoshikatsu Kanai, Jun Hatazawa
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1346;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Basic Science Posters

  • In Vivo PET/CT neuroimaging of radiolabeled nanocarriers following intranasal drug delivery (INDD): Validation using Ex Vivo PET/CT, gamma counting and autoradiography.
  • 18F-ML10 PET/CT demonstrates therapy-induced apoptosis in murine pancreatic adenocarcinoma
  • AFM promotes glucose metabolism in papillary thyroid carcinoma
Show more MTA I: Basic Science Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire